Expansion and Growth Onyx Scientific's recent expansion in Sunderland and the appointment of a Business Development Manager in North America indicate a strategic focus on increasing its footprint in the US market, presenting opportunities for partnerships and new client onboarding.

Global Regulatory Capabilities Operating from MHRA and FDA-licensed sites demonstrates its compliance with international standards, making it attractive to pharmaceutical companies seeking reliable partners for complex chemistry and GMP API production worldwide.

Target Market Focus With robust services spanning from medicinal chemistry to large-scale API manufacturing, Onyx Scientific serves a broad spectrum of pharmaceutical and biotech clients, offering multiple entry points for collaboration across development stages.

Technological Infrastructure Utilizing advanced tech tools like GMP-compliant facilities, process development, and scale-up capabilities, along with a modern tech stack, positions Onyx Scientific as a tech-savvy partner capable of supporting innovative drug development projects.

Mid-Size Market Position With revenue between $10M and $25M and a dedicated team, Onyx Scientific occupies a niche as a flexible and responsive CDMO, ideal for smaller to mid-sized pharma companies seeking personalized service without the scale constraints of larger providers.